Elçin ÖZÇELİK EROĞLU, M. İrem YILDIZ, A. Elif Anıl YAĞCIOĞLU, Özge TÜRKOĞLU, Oğuz Kaan YALÇINKAYA, Aygün ERTUĞRUL, Sevilay KARAHAN, M. Kâzım YAZICI

Effects of the COVID-19 Pandemic on Patients with Schizophrenia Spectrum Disorders

Objective: To evaluate the mental health of patients with schizophrenia spectrum disorders with the prolongation of the pandemic. Materials and Methods: This descriptive cross-sectional study was conducted between August-October 2020. Fifty-two patients with schizophrenia spectrum disorders who were hospitalized prior to the onset of the pandemic between March 2019-March 2020 at the inpatient clinic were reassessed during the pandemic. The Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression-Severity (CGI-S) Scale, Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A) and Fear of COVID-19 Scale were used to evaluate psychopathology during the pandemic. The PANSS and the CGI severity scores at discharge from the inpatient clinic for each patient were obtained from the medical records review for comparison along with sociodemographic variables. Results: A total of 34 patients, 33 with schizophrenia (97.1%) and 1 with schizoaffective disorder (2.9%) were included. There was no significant difference between the pre- and during the pandemic assessments in the PANSS total and the CGI severity scores. The PANSS total, the CGI, HAM-D, HAM-A and the Fear of COVID-19 scale scores, medical comorbidity and utilization of psychiatric health care services were significantly higher in patients who reported subjectively increased psychiatric symptoms during the pandemic. There was no significant difference in the change of PANSS total and CGI scores between the two groups. Fear of COVID-19 Scale and HAM-A scores were correlated positively. Conclusion: During pandemic increase in psychiatric symptoms may be related not only to psychosis but also depression, anxiety. According to the results of patients who reported subjectively increased psychiatric symptoms during the pandemic, while the psychotic symptoms did not worsen during the pandemic, patients with higher anxiety or depression scores reported an increase in their symptoms and were more likely to seek help.

PDF

___

[1] Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368: m1198.
[2] Padala SP, Dennis RA, Caceda R. Why COVID-19 Is Especially Difficult for Those With Schizophrenia: Reasons and Solutions. Prim Care Companion CNS Disord 2020; 2.
[3] Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry 2021;20:124-130.
[4] Kozloff N, Mulsant BH, Stergiopoulos V, et al. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disordersi Schizophr Bull 2020;46:752-757.
[5] Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence Lancet 2020;395:912-920.
[6] Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 epidemic in China: a web-based cross-sectional survey. Psychiatry Res 2020;288:112954.
[7] Wang C, Pan R, Wan X, et al.. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020;17:1729.
[8] Tso IF, Park S. Alarming levels of psychiatric symptoms and the role of loneliness during the COVID-19 epidemic: A case study of Hong Kong. Psychiatry Res 2020;293:113423.
[9] Zhand N, Joober R. 2021. Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review. BJPsych Open 2021;7:e35.
[10] Stefana A, Youngstrom EA, Chen J, et al. The COVID-19 pandemic is a crisis and opportunity for bipolar disorder. Bipolar Disord 2020;22:641-643.
[11] Pinkham AE, Ackerman RA, Depp CA, et al. A Longitudinal Investigation of the Effects of the COVID-19 Pandemic on the Mental Health of Individuals with Pre-existing Severe Mental Illnesses. Psychiatry Res 2020;294:113493.
[12] Koreki A, Nakane J, Kitada S, et al. Impact of COVID-19 on psychiatric day care services. Asian J Psychiatr 2020;54:102442.
[13] Hoşgelen EI, Alptekin K.COVID-19 Salgınının Şizofreni Hastalarındaki Etkisi. Turk J Psychiatry 2021. doi: 10.5080/ u26175.
[14] Barbato A. Schizophrenia and public health. WHO 1998.
[15] Sole B, Verdolini N, Amoretti S, et al. Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY. J Affect Disord 2021;281:13-23.
[16] Lakhan R, Agrawal A, Sharma M. Prevalence of Depression, Anxiety, and Stress during COVID-19 Pandemic, J Neurosci Rural Pract 2020;11:519-525.
[17] Kay SR, Fiszbein, A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
[18] Kostakoğlu AE, Batur S, Tiryaki A, et al. Pozitif ve negatif sendrom ölçeğinin (PANSS) Türkçe uyarlamasının geçerlilik ve güvenilirliği. Türk Psikoloji Dergisi 1999; 14: 23-32.
[19] Guy W. ECDEU Assessment Manual for Psychopharmacology’, US Department of Health and Human Services Publication 1976;218-222.
[20] Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychology 1967;6:278- 296.
[21] Aydemir A, Örsel S, Dağ I, et al. Hamilton Depresyon Derecelendirme Ölçeği (HDDÖ)’nin geçerliliği, güvenirliliği ve klinikte kullanımı. Psikiyatri Psikoloji Psikofarmakoloji Dergisi. 1996;4:251-259.
[22] Hamilton M. The assessment of anxiety states by rating, Br J Med Psychol 1959;32: 50-55.
[23] Yazıcı MK, Demir B, Tanrıverdi N, et al. Hamilton Anksiyete Değerlendirme Ölçeği, Değerlendiriciler Arası Güvenilirlik ve Geçerlilik Çalışması. Turk J Psychiatry1998;9:114-117.
[24] Matza LS, Morlock R, Sexton C, et al. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder Int J Methods Psychiatr Res 2010; 19: 223-232
[25] Ahorsu DK, Lin CY, Imani V, et al. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict 2020;1-9.
[26] Satici B, Gocet-Tekin E, Deniz ME, et al. Adaptation of the Fear of COVID-19 Scale: Its Association with Psychological Distress and Life Satisfaction in Turkey. Int J Ment Health Addict 2020;6:1980-1988.
[27] Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med 2020;383: 510-512.
[28] Lynch A, Bastiampillai T, Dhillon R. Can COVID-19-related anxiety trigger a relapse of schizophrenia? Aust N Z J Psychiatry 2020: 4867420954564.
[29] Brown ER, Gray S, Lo Monaco B, et al. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophr Res 2020;222:79-87.
[30] Hajduk M, Dancik D, Januska J, et al. Psychotic experiences in student population during the COVID-19 pandemic. Schizophr Res 2020; 222:520-521.
[31] Pan KY, Kok AAL, Eikelenboom, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry 2021;8:121-129.
[32] Horan WP, Ventura J, Mintz J, et al. Stress and coping responses to a natural disaster in people with schizophrenia. Psychiatry Res 2007;151:77-86.
[33] Katz CL, Pellegrino L, Pandya A, et al. Research on psychiatric outcomes and interventions subsequent to disasters: a review of the literature. Psychiatry Res 2020; 110:201-217.
[34] Morris MC, Evans LD, Rao U, et al. Executive function moderates the relation between coping and depressive symptoms. Anxiety Stress Coping 2015;28:31-49.
[35] Norris FH, Friedman MJ, Watson PJ, et al. 60,000 disaster victims speak: Part I. An empirical review of the empirical literature, 1981-2001. Psychiatry 2002;65:207-239.
[36] Violeau L, Valery KM, Fournier T, et al. How continuum beliefs can reduce stigma of schizophrenia: The role of perceived similarities. Schizophr Res 2020;220:46-53.
[37] Sayeed A, Kundu S, Al Banna MH, et al. Mental Health Outcomes of Adults with Comorbidity and Chronic Diseases during the COVID-19 Pandemic: A Matched Case- Control Study. Psychiatr Danub 2020;32:491-498.
[38] Gonzalez-Blanco L, Dal Santo F, Garcia-Alvarez L, et al. COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Schizophr Res 2020;223:192-198.
[39] Moreno C, Wykes T, Galderisi S, et al.. How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry 2020;7: 813-824.
[40] Goncalves-Pinho M, Mota P, Ribeiro Jet al The Impact of COVID-19 Pandemic on Psychiatric Emergency Department Visits - A Descriptive Study’, Psychiatr Q 2020;25:1-11.
[41] Šago D, Martiü V, Šmida D, et al. Telepsychiatry in the time of the covid-19 and earthquake in zagreb as odysseus between scylla and charybdis. Psychiatr Danub 2020;32: 478-481.